Angiotensin I II (1-6) TFA is a chemical compound comprising amino acids 1-6. It is derived from the Angiotensin I II peptide, which is formed by the cleavage of the precursor angiotensinogen by renin. The resulting Angiotensin I is then hydrolyzed by angiotensin-converting enzyme (ACE) to produce biologically active AngiotensinII. AngiotensinII has been extensively studied for its potential applications in the treatment of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Nephropathy[1][2][3].
Irbesartan is an angiotensinII receptor antagonist used mainly for the treatment of hypertension. It selectively and competitively blocks the binding of angiotensinII to the angiotensin I receptor.
PD 109488 is a metabolite of quinapril and is a derivative of Quinapril that acts as an ACE inhibitor. Inhibition of ACE prevents the conversion of signaling peptide angiotensin I into angiotensinII, which acts as a potent vasoconstrictor. Reduced levels of angiotensinII also reduces the amount of aldosterone that is expressed due to RAAS signaling.
Angiotensin I/II (1-7) amide is a peptide analog to angiotensinII that is used as a vasopressor in the treatment of certain types of shock and circulatory collapse. Angiotensin I/II amide is an amide derivative of angiotensinII that is a powerful vasoco
Angiotensin I II (2-7) is a peptide that contains the amino acids 2-7 and is converted from Angiotensin I II peptide. Angiotensin is a peptide hormone that causes vasoconstriction and a subsequent increase in blood pressure. Angiotensin also stimulates th
Angiotensin Fragment 1-7 is a type 1 angiotensinII receptor agonist. In the renin-angiotensin system, angiotensin I is cleaved by the angiotensin-converting enzyme to form angiotensinII, which has effects on fluid and electrolyte, as well as homeostasis